
Loading, please wait...

Loading, please wait...

The National Medical Commission (NMC) has issued a critical directive to all medical colleges and postgraduate institutions in India. They must submit information regarding NEET PG 2025 admissions for the academic year 2025-26 through the Admission Monitoring Portal. This crucial online submission window will close on April 8, 2026. Therefore, all concerned institutions must act promptly to ensure compliance with this directive.
This notification refers to a Public Notice issued by the Postgraduate Medical Education Board (PGMEB) of the NMC on March 30, 2026. Subsequently, the NMC has reiterated the importance of this online data filling process. The primary objective is to maintain transparency and adherence to regulations in postgraduate medical admissions. Consequently, colleges must meticulously upload all required details.
The National Medical Commission Act, 2019, underpins these regulations. It ensures that admissions to PG Diploma, MD/MS, DM, and M.Ch. courses align with judicial decisions and established MCI/NMC Regulations.
Medical colleges are required to ensure that all postgraduate admissions are strictly merit-based and transparent. Any deviation from these regulations may result in the discharge of students and action against the institution. Therefore, accurate and timely data submission is paramount.
To facilitate this, colleges should visit the NMC website homepage, specifically the "COLLEGE LOGIN" section. The portal URL is https://www.nmc.org.in/ActivitiWebClient/login. You must use existing login credentials, noting that the User ID and password are case-sensitive. Moreover, provision is available to change a forgotten password. Learn more about NMC guidelines.
The onus of providing true, correct, and authentic information rests solely with the concerned college. Any incorrect submission may prompt the NMC to initiate legal action. Furthermore, only data uploaded through the Student Admission Entry portal will be used for monitoring purposes. Hard copies are not required.
If colleges experience any difficulty accessing the NMC website or logging in, they should send an email to support.pgmonitoring@nmc.org.in with the subject "Difficulty in logging in." Ultimately, student names will not appear on the NMC website if their details are not submitted by the deadline.
State and Union Territory Directorates of Medical Education also need to submit admission details via email within two weeks of the last admission date. Additionally, the Medical Counselling Committee (MCC) conducts NEET PG counselling for various quota seats.
Disclaimer: This content is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


NMC mandates medical colleges to upload NEET PG 2025 admissions data to its online portal by April 8, 2026. Timely and accurate submission is crucial....
6 months ago

Discover the crucial role of glymphatic dysfunction in stroke, where perivascular clearance failure and neuroinflammation exacerbate cerebral edema and post-stroke brain injury.
Today

A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday